{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:29:56Z","timestamp":1790980196267,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["681002"],"award-info":[{"award-number":["681002"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["825759"],"award-info":[{"award-number":["825759"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Projekt DEAL"},{"DOI":"10.13039\/501100010583","name":"Universit\u00e4t Konstanz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010583","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inhibition of complex I of the mitochondrial respiratory chain (cI) by rotenone and methyl-phenylpyridinium (MPP\u2009+) leads to the degeneration of dopaminergic neurons in man and rodents. To formally describe this mechanism of toxicity, an adverse outcome pathway (AOP:3) has been developed that implies that any inhibitor of cI, or possibly of other parts of the respiratory chain, would have the potential to trigger parkinsonian motor deficits. We used here 21 pesticides, all of which are described in the literature as mitochondrial inhibitors, to study the general applicability of AOP:3 or of in vitro assays that are assessing its activation. Five cI, three complex II (cII), and five complex III (cIII) inhibitors were characterized in detail in human dopaminergic neuronal cell cultures. The NeuriTox assay, examining neurite damage in LUHMES cells, was used as in vitro proxy of the adverse outcome (AO), i.e., of dopaminergic neurodegeneration. This test provided data on whether test compounds were unspecific cytotoxicants or specifically neurotoxic, and it yielded potency data with respect to neurite degeneration. The pesticide panel was also examined in assays for the sequential key events (KE) leading to the AO, i.e., mitochondrial respiratory chain inhibition, mitochondrial dysfunction, and disturbed proteostasis. Data from KE assays were compared to the NeuriTox data (AO). The cII-inhibitory pesticides tested here did not appear to trigger the AOP:3 at all. Some of the cI\/cIII inhibitors showed a consistent AOP activation response in all assays, while others did not. In general, there was a clear hierarchy of assay sensitivity: changes of gene expression (biomarker of neuronal stress) correlated well with NeuriTox data; mitochondrial failure (measured both by a mitochondrial membrane potential-sensitive dye and a respirometric assay) was about 10\u2013260 times more sensitive than neurite damage (AO); cI\/cIII activity was sometimes affected at\u2009&gt;\u20091000 times lower concentrations than the neurites. These data suggest that the use of AOP:3 for hazard assessment has a number of caveats: (i) specific parkinsonian neurodegeneration cannot be easily predicted from assays of mitochondrial dysfunction; (ii) deriving a point-of-departure for risk assessment from early KE assays may overestimate toxicant potency.<\/jats:p>","DOI":"10.1007\/s00204-020-02970-5","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T04:42:05Z","timestamp":1611895325000},"page":"591-615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors"],"prefix":"10.1007","volume":"95","author":[{"given":"Johannes","family":"Delp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cediel-Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-9982","authenticated-orcid":false,"given":"Ilinca","family":"Suciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kranaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara MA","family":"van Vugt-Lussenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Munic Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"van der Stel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne Hougaard","family":"Bennekou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"van de Water","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Forsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Leist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"issue":"12","key":"2970_CR1","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1021\/tx500345j","volume":"27","author":"TE Allen","year":"2014","unstructured":"Allen TE, Goodman JM, Gutsell S, Russell PJ (2014) Defining molecular initiating events in the adverse outcome pathway framework for risk assessment. Chem Res Toxicol 27(12):2100\u20132112. https:\/\/doi.org\/10.1021\/tx500345j","journal-title":"Chem Res Toxicol"},{"key":"2970_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.neuro.2016.05.010","volume":"59","author":"A Bal-Price","year":"2017","unstructured":"Bal-Price A, Lein PJ, Keil KP et al (2017) Developing and applying the adverse outcome pathway concept for understanding and predicting neurotoxicity. Neurotoxicology 59:240\u2013255. https:\/\/doi.org\/10.1016\/j.neuro.2016.05.010","journal-title":"Neurotoxicology"},{"key":"2970_CR3","doi-asserted-by":"publisher","unstructured":"Bal-Price A, Leist M, Schildknecht S, Tschudi-Monnet F, Paini A, Terron A (2018) Adverse outcome pathway on inhibition of the mitochondrial complex I of nigro-striatal neurons leading to parkinsonian motor deficits. OECD Publishing, Paris. https:\/\/doi.org\/10.1787\/b46c3c00-en","DOI":"10.1787\/b46c3c00-en"},{"key":"2970_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.freeradbiomed.2016.08.010","volume":"100","author":"TS Blacker","year":"2016","unstructured":"Blacker TS, Duchen MR (2016) Investigating mitochondrial redox state using NADH and NADPH autofluorescence. Free Radic Biol Med 100:53\u201365. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.08.010","journal-title":"Free Radic Biol Med"},{"key":"2970_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2017.07.033","volume":"112","author":"J Blecha","year":"2017","unstructured":"Blecha J, Novais SM, Rohlenova K et al (2017) Antioxidant defense in quiescent cells determines selectivity of electron transport chain inhibition-induced cell death. Free Radic Biol Med 112:253\u2013266. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.07.033","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"2970_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1021\/acs.chemrestox.5b00407","volume":"29","author":"EA Blomme","year":"2016","unstructured":"Blomme EA, Will Y (2016) Toxicology strategies for drug discovery: present and future. Chem Res Toxicol 29(4):473\u2013504. https:\/\/doi.org\/10.1021\/acs.chemrestox.5b00407","journal-title":"Chem Res Toxicol"},{"key":"2970_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tiv.2018.04.012","volume":"51","author":"S Borchard","year":"2018","unstructured":"Borchard S, Bork F, Rieder T et al (2018) The exceptional sensitivity of brain mitochondria to copper. Toxicol In Vitro 51:11\u201322. https:\/\/doi.org\/10.1016\/j.tiv.2018.04.012","journal-title":"Toxicol In Vitro"},{"issue":"1","key":"2970_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0014-4827(74)90210-9","volume":"85","author":"BR Brinkley","year":"1974","unstructured":"Brinkley BR, Barham SS, Barranco SC, Fuller GM (1974) Rotenone inhibition of spindle microtubule assembly in mammalian cells. Exp Cell Res 85(1):41\u201346. https:\/\/doi.org\/10.1016\/0014-4827(74)90210-9","journal-title":"Exp Cell Res"},{"issue":"1","key":"2970_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1039\/c5tx00197h","volume":"5","author":"AJ Broom","year":"2016","unstructured":"Broom AJ, Ambroso J, Brunori G et al (2016) Effects of mid-respiratory chain inhibition on mitochondrial function in vitro and in vivo. Toxicol Res (Camb) 5(1):136\u2013150. https:\/\/doi.org\/10.1039\/c5tx00197h","journal-title":"Toxicol Res (Camb)"},{"issue":"14","key":"2970_CR10","doi-asserted-by":"publisher","first-page":"8804","DOI":"10.1021\/acs.est.5b02641","volume":"49","author":"P Browne","year":"2015","unstructured":"Browne P, Judson RS, Casey WM, Kleinstreuer NC, Thomas RS (2015) Screening chemicals for estrogen receptor bioactivity using a computational model. Environ Sci Technol 49(14):8804\u20138814. https:\/\/doi.org\/10.1021\/acs.est.5b02641","journal-title":"Environ Sci Technol"},{"issue":"9","key":"2970_CR11","doi-asserted-by":"publisher","first-page":"096001","DOI":"10.1289\/EHP1304","volume":"125","author":"P Browne","year":"2017","unstructured":"Browne P, Noyes PD, Casey WM, Dix DJ (2017) Application of adverse outcome pathways to U.S. EPA\u2019s endocrine disruptor screening program. Environ Health Perspect 125(9):096001. https:\/\/doi.org\/10.1289\/EHP1304","journal-title":"Environ Health Perspect"},{"key":"2970_CR12","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1911111","author":"M Br\u00fcll","year":"2020","unstructured":"Br\u00fcll M, Spreng AS, Gutbier S et al (2020) Incorporation of stem cell-derived astrocytes into neuronal organoids to allow neuro-glial interactions in toxicological studies. Altex. https:\/\/doi.org\/10.14573\/altex.1911111","journal-title":"Altex"},{"issue":"9","key":"2970_CR13","doi-asserted-by":"publisher","first-page":"e44700","DOI":"10.1371\/journal.pone.0044700","volume":"7","author":"Y Cabeza-Arvelaiz","year":"2012","unstructured":"Cabeza-Arvelaiz Y, Schiestl RH (2012) Transcriptome analysis of a rotenone model of parkinsonism reveals complex I-tied and -untied toxicity mechanisms common to neurodegenerative diseases. PLoS ONE 7(9):e44700. https:\/\/doi.org\/10.1371\/journal.pone.0044700","journal-title":"PLoS ONE"},{"issue":"1","key":"2970_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuro.2008.11.001","volume":"30","author":"Y-T Cheung","year":"2009","unstructured":"Cheung Y-T, Lau WK-W, Yu M-S et al (2009) Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. NeuroToxicology 30(1):127\u2013135. https:\/\/doi.org\/10.1016\/j.neuro.2008.11.001","journal-title":"NeuroToxicology"},{"issue":"2","key":"2970_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00204-018-2354-1","volume":"93","author":"IM Copple","year":"2019","unstructured":"Copple IM, den Hollander W, Callegaro G et al (2019) Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury. Arch Toxicol 93(2):385\u2013399. https:\/\/doi.org\/10.1007\/s00204-018-2354-1","journal-title":"Arch Toxicol"},{"issue":"5","key":"2970_CR16","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00204-016-1698-7","volume":"90","author":"M Daneshian","year":"2016","unstructured":"Daneshian M, Kamp H, Hengstler J, Leist M, van de Water B (2016) Highlight report: launch of a large integrated European in vitro toxicology project: EU-ToxRisk. Arch Toxicol 90(5):1021\u20131024. https:\/\/doi.org\/10.1007\/s00204-016-1698-7","journal-title":"Arch Toxicol"},{"key":"2970_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.taap.2017.12.013","volume":"354","author":"J Delp","year":"2018","unstructured":"Delp J, Gutbier S, Cerff M et al (2018a) Stage-specific metabolic features of differentiating neurons: implications for toxicant sensitivity. Toxicol Appl Pharmacol 354:64\u201380. https:\/\/doi.org\/10.1016\/j.taap.2017.12.013","journal-title":"Toxicol Appl Pharmacol"},{"key":"2970_CR18","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1712182","author":"J Delp","year":"2018","unstructured":"Delp J, Gutbier S, Klima S et al (2018b) A high-throughput approach to identify specific neurotoxicants\/ developmental toxicants in human neuronal cell function assays. Altex. https:\/\/doi.org\/10.14573\/altex.1712182","journal-title":"Altex"},{"issue":"6","key":"2970_CR19","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00204-019-02473-y","volume":"93","author":"J Delp","year":"2019","unstructured":"Delp J, Funke M, Rudolf F et al (2019) Development of a neurotoxicity assay that is tuned to detect mitochondrial toxicants. Arch Toxicol 93(6):1585\u20131608. https:\/\/doi.org\/10.1007\/s00204-019-02473-y","journal-title":"Arch Toxicol"},{"issue":"5","key":"2970_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/026119291604400504","volume":"44","author":"N Delrue","year":"2016","unstructured":"Delrue N, Sachana M, Sakuratani Y, Gourmelon A, Leinala E, Diderich R (2016) The adverse outcome pathway concept: a basis for developing regulatory decision-making tools. Altern Lab Anim 44(5):417\u2013429","journal-title":"Altern Lab Anim"},{"issue":"1","key":"2970_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00204-019-02612-5","volume":"94","author":"N Dreser","year":"2020","unstructured":"Dreser N, Madjar K, Holzer AK et al (2020) Development of a neural rosette formation assay (RoFA) to identify neurodevelopmental toxicants and to characterize their transcriptome disturbances. Arch Toxicol 94(1):151\u2013171. https:\/\/doi.org\/10.1007\/s00204-019-02612-5","journal-title":"Arch Toxicol"},{"issue":"16","key":"2970_CR22","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1111\/bph.13193","volume":"172","author":"L Efremova","year":"2015","unstructured":"Efremova L, Schildknecht S, Adam M et al (2015) Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism. Br J Pharmacol 172(16):4119\u20134132. https:\/\/doi.org\/10.1111\/bph.13193","journal-title":"Br J Pharmacol"},{"key":"2970_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-019-02591-7","author":"SE Escher","year":"2019","unstructured":"Escher SE, Kamp H, Bennekou SH et al (2019) Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-019-02591-7","journal-title":"Arch Toxicol"},{"issue":"7\u20138","key":"2970_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.bbabio.2008.04.033","volume":"1777","author":"U Fendel","year":"2008","unstructured":"Fendel U, Tocilescu MA, Kerscher S, Brandt U (2008) Exploring the inhibitor binding pocket of respiratory complex I. Biochim Biophys Acta 1777(7\u20138):660\u2013665. https:\/\/doi.org\/10.1016\/j.bbabio.2008.04.033","journal-title":"Biochim Biophys Acta"},{"key":"2970_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15571","author":"Y Feng","year":"2020","unstructured":"Feng Y, Ma J, Yuan L (2020) beta-Methylphenylalanine exerts neuroprotective effects in a Parkinson\u2019s disease model by protecting against tyrosine hydroxylase depletion. J Cell Mol Med. https:\/\/doi.org\/10.1111\/jcmm.15571","journal-title":"J Cell Mol Med"},{"issue":"7799","key":"2970_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41586-020-2076-4","volume":"579","author":"E Fessler","year":"2020","unstructured":"Fessler E, Eckl EM, Schmitt S et al (2020) A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol. Nature 579(7799):433\u2013437. https:\/\/doi.org\/10.1038\/s41586-020-2076-4","journal-title":"Nature"},{"issue":"8","key":"2970_CR27","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.tiv.2009.07.017","volume":"23","author":"A Forsby","year":"2009","unstructured":"Forsby A, Bal-Price AK, Camins A et al (2009) Neuronal in vitro models for the estimation of acute systemic toxicity. Toxicol In Vitro 23(8):1564\u20131569. https:\/\/doi.org\/10.1016\/j.tiv.2009.07.017","journal-title":"Toxicol In Vitro"},{"issue":"1\u20132","key":"2970_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1432-1033.1994.tb19985.x","volume":"219","author":"T Friedrich","year":"1994","unstructured":"Friedrich T, van Heek P, Leif H et al (1994) Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase. Eur J Biochem 219(1\u20132):691\u2013698. https:\/\/doi.org\/10.1111\/j.1432-1033.1994.tb19985.x","journal-title":"Eur J Biochem"},{"key":"2970_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02691-9","author":"E Gijbels","year":"2020","unstructured":"Gijbels E, Vilas-Boas V, Annaert P, Vanhaecke T, Devisscher L, Vinken M (2020) Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-020-02691-9","journal-title":"Arch Toxicol"},{"key":"2970_CR30","doi-asserted-by":"publisher","first-page":"104721","DOI":"10.1016\/j.yrtph.2020.104721","volume":"116","author":"N Gilmour","year":"2020","unstructured":"Gilmour N, Kern PS, Alepee N et al (2020) Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients. Regul Toxicol Pharmacol 116:104721. https:\/\/doi.org\/10.1016\/j.yrtph.2020.104721","journal-title":"Regul Toxicol Pharmacol"},{"key":"2970_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cotox.2019.03.005","volume":"15","author":"R Graepel","year":"2019","unstructured":"Graepel R, Ter Braak B, Escher SE et al (2019) Paradigm shift in safety assessment using new approach methods: the EU-ToxRisk strategy. Curr Opin Toxicol 15:33\u201339. https:\/\/doi.org\/10.1016\/j.cotox.2019.03.005","journal-title":"Curr Opin Toxicol"},{"issue":"1","key":"2970_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bj.2017.12.001","volume":"41","author":"R Guo","year":"2018","unstructured":"Guo R, Gu J, Zong S, Wu M, Yang M (2018) Structure and mechanism of mitochondrial electron transport chain. Biomed J 41(1):9\u201320. https:\/\/doi.org\/10.1016\/j.bj.2017.12.001","journal-title":"Biomed J"},{"issue":"2","key":"2970_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jnr.20142","volume":"77","author":"H Gustafsson","year":"2004","unstructured":"Gustafsson H, Soderdahl T, Jonsson G, Bratteng JO, Forsby A (2004) Insulin-like growth factor type 1 prevents hyperglycemia-induced uncoupling protein 3 down-regulation and oxidative stress. J Neurosci Res 77(2):285\u2013291. https:\/\/doi.org\/10.1002\/jnr.20142","journal-title":"J Neurosci Res"},{"issue":"2","key":"2970_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.taap.2010.02.018","volume":"245","author":"H Gustafsson","year":"2010","unstructured":"Gustafsson H, Runesson J, Lundqvist J, Lindegren H, Axelsson V, Forsby A (2010) Neurofunctional endpoints assessed in human neuroblastoma SH-SY5Y cells for estimation of acute systemic toxicity. Toxicol Appl Pharmacol 245(2):191\u2013202. https:\/\/doi.org\/10.1016\/j.taap.2010.02.018","journal-title":"Toxicol Appl Pharmacol"},{"key":"2970_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-018-2326-5","author":"S Gutbier","year":"2018","unstructured":"Gutbier S, May P, Berthelot S et al (2018a) Major changes of cell function and toxicant sensitivity in cultured cells undergoing mild, quasi-natural genetic drift. Arch Toxicol. https:\/\/doi.org\/10.1007\/s00204-018-2326-5","journal-title":"Arch Toxicol"},{"issue":"12","key":"2970_CR36","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/s41418-018-0229-x","volume":"25","author":"S Gutbier","year":"2018","unstructured":"Gutbier S, Spreng AS, Delp J et al (2018b) Prevention of neuronal apoptosis by astrocytes through thiol-mediated stress response modulation and accelerated recovery from proteotoxic stress. Cell Death Differ 25(12):2101\u20132117. https:\/\/doi.org\/10.1038\/s41418-018-0229-x","journal-title":"Cell Death Differ"},{"issue":"10","key":"2970_CR37","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1021\/acs.jpcb.5b12347","volume":"120","author":"MA Hagras","year":"2016","unstructured":"Hagras MA, Stuchebrukhov AA (2016) Novel inhibitors for a novel binding site in respiratory complex III. J Phys Chem B 120(10):2701\u20132708. https:\/\/doi.org\/10.1021\/acs.jpcb.5b12347","journal-title":"J Phys Chem B"},{"key":"2970_CR38","doi-asserted-by":"publisher","first-page":"165533","DOI":"10.1016\/j.bbadis.2019.165533","volume":"4","author":"DS Harischandra","year":"2020","unstructured":"Harischandra DS, Rokad D, Ghaisas S et al (2020) Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson\u2019s disease. Biochim Biophys Acta Mol Basis Dis 4:165533. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165533","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"2970_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0005-2728(03)00060-4","volume":"1605","author":"T Ino","year":"2003","unstructured":"Ino T, Nishioka T, Miyoshi H (2003) Characterization of inhibitor binding sites of mitochondrial complex I using fluorescent inhibitor. Biochimica et Biophysica Acta (BBA) 1605(1):15\u201320. https:\/\/doi.org\/10.1016\/S0005-2728(03)00060-4","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"2","key":"2970_CR40","doi-asserted-by":"publisher","first-page":"E374","DOI":"10.1152\/ajpendo.00088.2019","volume":"317","author":"L Kappler","year":"2019","unstructured":"Kappler L, Hoene M, Hu C et al (2019) Linking bioenergetic function of mitochondria to tissue-specific molecular fingerprints. Am J Physiol Endocrinol Metab 317(2):E374\u2013E387. https:\/\/doi.org\/10.1152\/ajpendo.00088.2019","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"2970_CR41","doi-asserted-by":"publisher","first-page":"518","DOI":"10.14573\/altex.1906251","volume":"36","author":"C Karreman","year":"2019","unstructured":"Karreman C, Kranaster P, Leist M (2019) SUIKER: quantification of antigens in cell organelles, neurites and cellular sub-structures by imaging. Altex 36(3):518\u2013520. https:\/\/doi.org\/10.14573\/altex.1906251","journal-title":"Altex"},{"issue":"23","key":"2970_CR42","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1016\/j.bmcl.2017.10.048","volume":"27","author":"SM Kim","year":"2017","unstructured":"Kim SM, Park YJ, Shin MS et al (2017) Acacetin inhibits neuronal cell death induced by 6-hydroxydopamine in cellular Parkinson\u2019s disease model. Bioorg Med Chem Lett 27(23):5207\u20135212. https:\/\/doi.org\/10.1016\/j.bmcl.2017.10.048","journal-title":"Bioorg Med Chem Lett"},{"key":"2970_CR43","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.reprotox.2018.08.017","volume":"81","author":"NC Kleinstreuer","year":"2018","unstructured":"Kleinstreuer NC, Browne P, Chang X et al (2018) Evaluation of androgen assay results using a curated Hershberger database. Reprod Toxicol 81:272\u2013280. https:\/\/doi.org\/10.1016\/j.reprotox.2018.08.017","journal-title":"Reprod Toxicol"},{"issue":"2","key":"2970_CR44","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00204-019-02642-z","volume":"94","author":"P Kranaster","year":"2020","unstructured":"Kranaster P, Karreman C, Dold J et al (2020) Time and space-resolved quantification of plasma membrane sialylation for measurements of cell function and neurotoxicity. Arch Toxicol 94(2):449\u2013467. https:\/\/doi.org\/10.1007\/s00204-019-02642-z","journal-title":"Arch Toxicol"},{"issue":"1","key":"2970_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.14573\/altex.1912021","volume":"37","author":"A Krebs","year":"2020","unstructured":"Krebs A, Nyffeler J, Karreman C et al (2020) Determination of benchmark concentrations and their statistical uncertainty for cytotoxicity test data and functional in vitro assays. Altex 37(1):155\u2013163. https:\/\/doi.org\/10.14573\/altex.1912021","journal-title":"Altex"},{"issue":"12","key":"2970_CR46","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1007\/s00204-013-1072-y","volume":"87","author":"AK Krug","year":"2013","unstructured":"Krug AK, Balmer NV, Matt F, Schonenberger F, Merhof D, Leist M (2013a) Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants. Arch Toxicol 87(12):2215\u20132231. https:\/\/doi.org\/10.1007\/s00204-013-1072-y","journal-title":"Arch Toxicol"},{"issue":"1","key":"2970_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00204-012-0967-3","volume":"87","author":"AK Krug","year":"2013","unstructured":"Krug AK, Kolde R, Gaspar JA et al (2013b) Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol 87(1):123\u2013143. https:\/\/doi.org\/10.1007\/s00204-012-0967-3","journal-title":"Arch Toxicol"},{"key":"2970_CR48","doi-asserted-by":"publisher","first-page":"e1222","DOI":"10.1038\/cddis.2014.166","volume":"5","author":"AK Krug","year":"2014","unstructured":"Krug AK, Gutbier S, Zhao L et al (2014) Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+). Cell Death Dis 5:e1222. https:\/\/doi.org\/10.1038\/cddis.2014.166","journal-title":"Cell Death Dis"},{"issue":"2","key":"2970_CR49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.expneurol.2005.03.005","volume":"194","author":"B Lai","year":"2005","unstructured":"Lai B, Zhang L, Dong LY, Zhu YH, Sun FY, Zheng P (2005) Inhibition of Qi site of mitochondrial complex III with antimycin A decreases persistent and transient sodium currents via reactive oxygen species and protein kinase C in rat hippocampal CA1 cells. Exp Neurol 194(2):484\u2013494. https:\/\/doi.org\/10.1016\/j.expneurol.2005.03.005","journal-title":"Exp Neurol"},{"issue":"11","key":"2970_CR50","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1007\/s00204-017-2045-3","volume":"91","author":"M Leist","year":"2017","unstructured":"Leist M, Ghallab A, Graepel R et al (2017) Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol 91(11):3477\u20133505. https:\/\/doi.org\/10.1007\/s00204-017-2045-3","journal-title":"Arch Toxicol"},{"issue":"4","key":"2970_CR51","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1080\/10807039.2015.1133242","volume":"22","author":"KA Lewis","year":"2016","unstructured":"Lewis KA, Tzilivakis J, Warner DJ, Green A (2016) An international database for pesticide risk assessments and management. Hum Ecol Risk Assess 22(4):1050\u20131064. https:\/\/doi.org\/10.1080\/10807039.2015.1133242","journal-title":"Hum Ecol Risk Assess"},{"key":"2970_CR52","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.brainres.2010.03.102","volume":"1337","author":"FM Lopes","year":"2010","unstructured":"Lopes FM, Schr\u00f6der R, J\u00fanior MLCdF et al (2010) Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies. Brain Res 1337:85\u201394. https:\/\/doi.org\/10.1016\/j.brainres.2010.03.102","journal-title":"Brain Res"},{"issue":"12","key":"2970_CR53","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"2970_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0647-2","author":"L Matelski","year":"2020","unstructured":"Matelski L, Morgan RK, Grodzki AC, Van de Water J, Lein PJ (2020) Effects of cytokines on nuclear factor-kappa B, cell viability, and synaptic connectivity in a human neuronal cell line. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-020-0647-2","journal-title":"Mol Psychiatry"},{"issue":"1","key":"2970_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/A:1022017731328","volume":"19","author":"M Nordin-Andersson","year":"2003","unstructured":"Nordin-Andersson M, Walum E, Kjellstrand P, Forsby A (2003) Acrylamide-induced effects on general and neurospecific cellular functions during exposure and recovery. Cell Biol Toxicol 19(1):43\u201351","journal-title":"Cell Biol Toxicol"},{"issue":"3","key":"2970_CR56","doi-asserted-by":"publisher","first-page":"e04691","DOI":"10.2903\/j.efsa.2017.4691","volume":"15","author":"C Ockleford","year":"2017","unstructured":"Ockleford C, Adriaanse P, Berny P et al (2017) Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson\u2019s disease and childhood leukaemia\u2020. EFSA J 15(3):e04691. https:\/\/doi.org\/10.2903\/j.efsa.2017.4691","journal-title":"EFSA J"},{"issue":"7","key":"2970_CR57","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1248\/bpb.29.1401","volume":"29","author":"K Okuda","year":"2006","unstructured":"Okuda K, Kotake Y, Ohta S (2006) Parkinsonism-preventing activity of 1-methyl-1,2,3,4-tetrahydroisoquinoline derivatives in C57BL mouse in vivo. Biol Pharm Bull 29(7):1401\u20131403. https:\/\/doi.org\/10.1248\/bpb.29.1401","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"2970_CR58","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1074\/jbc.274.5.2625","volume":"274","author":"JG Okun","year":"1999","unstructured":"Okun JG, Lummen P, Brandt U (1999) Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase). J Biol Chem 274(5):2625\u20132630. https:\/\/doi.org\/10.1074\/jbc.274.5.2625","journal-title":"J Biol Chem"},{"issue":"8","key":"2970_CR59","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1007\/s11064-020-03061-8","volume":"45","author":"S Pakrashi","year":"2020","unstructured":"Pakrashi S, Chakraborty J, Bandyopadhyay J (2020) Neuroprotective role of quercetin on rotenone-induced toxicity in SH-SY5Y cell line through modulation of apoptotic and autophagic pathways. Neurochem Res 45(8):1962\u20131973. https:\/\/doi.org\/10.1007\/s11064-020-03061-8","journal-title":"Neurochem Res"},{"issue":"3","key":"2970_CR60","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00418-017-1577-1","volume":"148","author":"JB Passmore","year":"2017","unstructured":"Passmore JB, Pinho S, Gomez-Lazaro M, Schrader M (2017) The respiratory chain inhibitor rotenone affects peroxisomal dynamics via its microtubule-destabilising activity. Histochem Cell Biol 148(3):331\u2013341. https:\/\/doi.org\/10.1007\/s00418-017-1577-1","journal-title":"Histochem Cell Biol"},{"issue":"1\u20132","key":"2970_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10863-012-9477-5","volume":"45","author":"NR Perron","year":"2013","unstructured":"Perron NR, Beeson C, Rohrer B (2013) Early alterations in mitochondrial reserve capacity; a means to predict subsequent photoreceptor cell death. J Bioenerg Biomembr 45(1\u20132):101\u2013109. https:\/\/doi.org\/10.1007\/s10863-012-9477-5","journal-title":"J Bioenerg Biomembr"},{"key":"2970_CR62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nbd.2018.02.007","volume":"114","author":"SE Pierce","year":"2018","unstructured":"Pierce SE, Tyson T, Booms A, Prahl J, Coetzee GA (2018) Parkinson\u2019s disease genetic risk in a midbrain neuronal cell line. Neurobiol Dis 114:53\u201364. https:\/\/doi.org\/10.1016\/j.nbd.2018.02.007","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2970_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12940-020-00578-x","volume":"19","author":"F Pistollato","year":"2020","unstructured":"Pistollato F, de Gyves EM, Carpi D et al (2020) Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept. Environ Health 19(1):1\u201326","journal-title":"Environ Health"},{"issue":"40","key":"2970_CR64","doi-asserted-by":"publisher","first-page":"34105","DOI":"10.1074\/jbc.M503483200","volume":"280","author":"Y Ren","year":"2005","unstructured":"Ren Y, Liu W, Jiang H, Jiang Q, Feng J (2005) Selective vulnerability of dopaminergic neurons to microtubule depolymerization. J Biol Chem 280(40):34105\u201334112. https:\/\/doi.org\/10.1074\/jbc.M503483200","journal-title":"J Biol Chem"},{"issue":"6","key":"2970_CR65","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1042\/bst0311095","volume":"31","author":"PR Rich","year":"2003","unstructured":"Rich PR (2003) The molecular machinery of Keilin\u2019s respiratory chain. Biochem Soc Trans 31(6):1095\u20131105. https:\/\/doi.org\/10.1042\/bst0311095","journal-title":"Biochem Soc Trans"},{"issue":"50","key":"2970_CR66","doi-asserted-by":"publisher","first-page":"14893","DOI":"10.1021\/ja027748x","volume":"124","author":"E Saxon","year":"2002","unstructured":"Saxon E, Luchansky SJ, Hang HC, Yu C, Lee SC, Bertozzi CR (2002) Investigating cellular metabolism of synthetic azidosugars with the Staudinger ligation. J Am Chem Soc 124(50):14893\u201314902. https:\/\/doi.org\/10.1021\/ja027748x","journal-title":"J Am Chem Soc"},{"issue":"1","key":"2970_CR67","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.taap.2009.07.027","volume":"241","author":"S Schildknecht","year":"2009","unstructured":"Schildknecht S, Poltl D, Nagel DM et al (2009) Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. Toxicol Appl Pharmacol 241(1):23\u201335. https:\/\/doi.org\/10.1016\/j.taap.2009.07.027","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"2970_CR68","doi-asserted-by":"publisher","first-page":"427","DOI":"10.14573\/altex.2013.4.427","volume":"30","author":"S Schildknecht","year":"2013","unstructured":"Schildknecht S, Karreman C, Poltl D et al (2013) Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases. Altex 30(4):427\u2013444. https:\/\/doi.org\/10.14573\/altex.2013.4.427","journal-title":"Altex"},{"issue":"13","key":"2970_CR69","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1089\/ars.2015.6297","volume":"23","author":"S Schildknecht","year":"2015","unstructured":"Schildknecht S, Pape R, Meiser J et al (2015) Preferential extracellular generation of the active parkinsonian toxin MPP+ by transporter-independent export of the intermediate MPDP+. Antioxid Redox Signal 23(13):1001\u20131016. https:\/\/doi.org\/10.1089\/ars.2015.6297","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"2970_CR70","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/j.1471-4159.2011.07255.x","volume":"119","author":"D Scholz","year":"2011","unstructured":"Scholz D, Poltl D, Genewsky A et al (2011) Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J Neurochem 119(5):957\u2013971. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07255.x","journal-title":"J Neurochem"},{"issue":"6","key":"2970_CR71","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/j.1471-4159.2006.04333.x","volume":"100","author":"TB Sherer","year":"2007","unstructured":"Sherer TB, Richardson JR, Testa CM et al (2007) Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson\u2019s disease. J Neurochem 100(6):1469\u20131479. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04333.x","journal-title":"J Neurochem"},{"issue":"10","key":"2970_CR72","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1007\/s00204-019-02551-1","volume":"93","author":"N Spinu","year":"2019","unstructured":"Spinu N, Bal-Price A, Cronin MTD, Enoch SJ, Madden JC, Worth AP (2019) Development and analysis of an adverse outcome pathway network for human neurotoxicity. Arch Toxicol 93(10):2759\u20132772. https:\/\/doi.org\/10.1007\/s00204-019-02551-1","journal-title":"Arch Toxicol"},{"issue":"18","key":"2970_CR73","doi-asserted-by":"publisher","first-page":"4788","DOI":"10.1111\/j.1742-4658.2007.06004.x","volume":"274","author":"P Srivastava","year":"2007","unstructured":"Srivastava P, Panda D (2007) Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding. FEBS J 274(18):4788\u20134801. https:\/\/doi.org\/10.1111\/j.1742-4658.2007.06004.x","journal-title":"FEBS J"},{"issue":"1","key":"2970_CR74","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/toxsci\/kfr034","volume":"121","author":"NV Stiegler","year":"2011","unstructured":"Stiegler NV, Krug AK, Matt F, Leist M (2011) Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. Toxicol Sci 121(1):73\u201387. https:\/\/doi.org\/10.1093\/toxsci\/kfr034","journal-title":"Toxicol Sci"},{"issue":"1","key":"2970_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00204-017-2133-4","volume":"92","author":"A Terron","year":"2018","unstructured":"Terron A, Bal-Price A, Paini A et al (2018) An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition. Arch Toxicol 92(1):41\u201382. https:\/\/doi.org\/10.1007\/s00204-017-2133-4","journal-title":"Arch Toxicol"},{"issue":"2","key":"2970_CR76","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/toxsci\/kfs159","volume":"128","author":"RS Thomas","year":"2012","unstructured":"Thomas RS, Black MB, Li L et al (2012) A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. Toxicol Sci 128(2):398\u2013417. https:\/\/doi.org\/10.1093\/toxsci\/kfs159","journal-title":"Toxicol Sci"},{"key":"2970_CR77","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.tiv.2018.07.012","volume":"52","author":"K Tilmant","year":"2018","unstructured":"Tilmant K, Gerets H, De Ron P, Hanon E, Bento-Pereira C, Atienzar FA (2018) In vitro screening of cell bioenergetics to assess mitochondrial dysfunction in drug development. Toxicol In Vitro 52:374\u2013383. https:\/\/doi.org\/10.1016\/j.tiv.2018.07.012","journal-title":"Toxicol In Vitro"},{"issue":"2","key":"2970_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jat.3334","volume":"37","author":"Z-B Tong","year":"2017","unstructured":"Tong Z-B, Hogberg H, Kuo D et al (2017) Characterization of three human cell line models for high-throughput neuronal cytotoxicity screening. J Appl Toxicol 37(2):167\u2013180. https:\/\/doi.org\/10.1002\/jat.3334","journal-title":"J Appl Toxicol"},{"key":"2970_CR79","doi-asserted-by":"publisher","first-page":"100123","DOI":"10.1016\/j.comtox.2020.100123","volume":"14","author":"F Troger","year":"2020","unstructured":"Troger F, Delp J, Funke M et al (2020) Identification of mitochondrial toxicants by combined in silico and in vitro studies\u2014A structure-based view on the adverse outcome pathway. Comput Toxicol 14:100123. https:\/\/doi.org\/10.1016\/j.comtox.2020.100123","journal-title":"Comput Toxicol"},{"issue":"3","key":"2970_CR80","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1534\/genetics.117.300262","volume":"207","author":"AM van der Bliek","year":"2017","unstructured":"van der Bliek AM, Sedensky MM, Morgan PG (2017) Cell Biology of the Mitochondrion. Genetics 207(3):843\u2013871. https:\/\/doi.org\/10.1534\/genetics.117.300262","journal-title":"Genetics"},{"issue":"8","key":"2970_CR81","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1007\/s00204-020-02792-5","volume":"94","author":"W van der Stel","year":"2020","unstructured":"van der Stel W, Carta G, Eakins J et al (2020) Multiparametric assessment of mitochondrial respiratory inhibition in HepG2 and RPTEC\/TERT1 cells using a panel of mitochondrial targeting agrochemicals. Arch Toxicol 94(8):2707\u20132729. https:\/\/doi.org\/10.1007\/s00204-020-02792-5","journal-title":"Arch Toxicol"},{"key":"2970_CR82","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tox.2013.08.011","volume":"312","author":"M Vinken","year":"2013","unstructured":"Vinken M (2013) The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology 312:158\u2013165. https:\/\/doi.org\/10.1016\/j.tox.2013.08.011","journal-title":"Toxicology"},{"issue":"5","key":"2970_CR83","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00204-018-2178-z","volume":"92","author":"S Wink","year":"2018","unstructured":"Wink S, Hiemstra SW, Huppelschoten S, Klip JE, van de Water B (2018) Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury. Arch Toxicol 92(5):1797\u20131814. https:\/\/doi.org\/10.1007\/s00204-018-2178-z","journal-title":"Arch Toxicol"},{"issue":"9","key":"2970_CR84","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1007\/s00204-017-1933-x","volume":"91","author":"B Witt","year":"2017","unstructured":"Witt B, Meyer S, Ebert F, Francesconi KA, Schwerdtle T (2017) Toxicity of two classes of arsenolipids and their water-soluble metabolites in human differentiated neurons. Arch Toxicol 91(9):3121\u20133134. https:\/\/doi.org\/10.1007\/s00204-017-1933-x","journal-title":"Arch Toxicol"},{"issue":"8","key":"2970_CR85","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3760\/cma.j.issn.0366-6999.2010.08.021","volume":"123","author":"H-r Xie","year":"2010","unstructured":"Xie H-r, Hu L-s, Li G-y (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chin Med J 123(8):1086\u20131092. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.2010.08.021","journal-title":"Chin Med J"},{"issue":"5","key":"2970_CR86","doi-asserted-by":"publisher","first-page":"e0178302","DOI":"10.1371\/journal.pone.0178302","volume":"12","author":"JM Yeakley","year":"2017","unstructured":"Yeakley JM, Shepard PJ, Goyena DE, VanSteenhouse HC, McComb JD, Seligmann BE (2017) A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS ONE 12(5):e0178302. https:\/\/doi.org\/10.1371\/journal.pone.0178302","journal-title":"PLoS ONE"},{"key":"2970_CR87","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fgene.2018.00429","volume":"9","author":"E Zgheib","year":"2018","unstructured":"Zgheib E, Limonciel A, Jiang X et al (2018) Investigation of Nrf2, AhR and ATF4 activation in toxicogenomic databases. Front Genet 9:429. https:\/\/doi.org\/10.3389\/fgene.2018.00429","journal-title":"Front Genet"},{"key":"2970_CR88","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jes.2015.07.001","volume":"35","author":"B Zhou","year":"2015","unstructured":"Zhou B (2015) Adverse outcome pathway: framework, application, and challenges in chemical risk assessment. J Environ Sci (China) 35:191\u2013193. https:\/\/doi.org\/10.1016\/j.jes.2015.07.001","journal-title":"J Environ Sci (China)"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02970-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-020-02970-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-020-02970-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T20:28:50Z","timestamp":1612902530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-020-02970-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2970"],"URL":"https:\/\/doi.org\/10.1007\/s00204-020-02970-5","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"16 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}